Skip to main content
. 2019 Jun 1;16:116. doi: 10.1186/s12974-019-1510-8

Fig. 1.

Fig. 1

Flow cytometric characterization of populations of CNS immune cells in the tMCAO model. a Experimental design and flow cytometric gating strategy: Following tMCAO, CNS-MPs were acutely isolated at 30 min, 24 h, 48 h, 72 h, and 7 days timepoints and characterized by flow-cytometry based on CD11b, CD45, and Ly6c expression. In independent experiments with viability indicators, viability of > 99% was confirmed using this gating strategy. b Comparison of CD45high cells within CD11b+ CNS-MPs. Quantitative analysis is shown on the right. c Subpopulations of CD11b+ CNS-MPs based on CD45 and Ly6c expression and temporal patterns post-tMCAO. An example of CD11b+ subpopulations from the ischemic hemisphere at 72 h post-tMCAO is shown on the left. Quantitative analysis of relative proportions of Ly6chigh and Ly6clow subsets of CD11b+CD45high cells in ipsilateral and contralateral hemispheres at various timepoints is shown. N = 4–8 mice/group, error bars represent standard error of mean. *indicates comparisons between hemispheres (*p < 0.05, **p < 0.01, ***p < 0.005). #indicates comparisons within ipsilateral hemispheres across timepoints using 30 min timepoint as reference (#p < 0.05, ##p < 0.01, ###p < 0.005)